Expected outcomes
What should improve.
- Reduced shedding over the first 8-16 weeks
- Improved density trend over 4-9 months depending on pattern type
- Higher treatment consistency through structured monitoring

Protocol Provider review
DHT, ferritin, thyroid, and adherence-centered treatment sequencing for hair recovery.
Medically reviewed byDr. Priya Rao, MD
OB-GYN, Women's Health Lead - updated April 2026How we review
Best fit
We screen eligibility before any prescription enters the conversation. Decline is treated as an outcome, not a failure.
Contraindications
These are hard stops. We route into a different protocol or refer out, rather than working around a contraindication.
Execution
Each phase has explicit entry criteria, actions, and exit conditions. The plan moves on data and tolerance, not a calendar.
Phase 01
Weeks 0-3
Distinguish androgenic pattern loss from systemic shedding contributors.
Phase 02
Weeks 4-16
Begin route-specific pharmacologic and behavioral regimen with adherence tracking.
Phase 03
Weeks 17-36+
Assess response quality and decide continuation, escalation, or switch.
Stack components
Prescription
Provider-selected and state-dependent.
Labs
Supplements
Coaching
Expected outcomes
Risk picture
Monitoring cadence
Labs and availability
Common questions
Evidence
Trials, regulatory guidance, and peer-reviewed evidence the protocol is anchored against.
Keep reading
ALUKARD vs Hims: protocol depth versus speed and simplicity
Both platforms improve access, but they optimize for different outcomes. Hims emphasizes speed and convenience. ALUKARD emphasizes biomarker-first protocol...
ReadALUKARD vs Ro: eligibility rigor versus rapid telehealth flow
Ro and ALUKARD both serve telehealth demand, but their operating assumptions differ. Ro leans into broad, efficient pathway delivery; ALUKARD leans into...
ReadMen's Health
Low T is rarely the whole answer. Thyroid, sleep, iron, lipids, and training load shape the outcome before testosterone does.
ReadWomen's Health
Ferritin and thyroid get missed more often than hormones do. We read labs across your cycle, not against a one-size reference range.
ReadCreatine, protein, and the two supplements that actually moved your labs
The supplement aisle sells 200 ingredients. The list with real human evidence and clinically meaningful effect sizes is shorter than five. Here's the honest...
ReadFerritin and iron for women: the missed root cause behind fatigue and hair loss
A ferritin of 22 ng/mL is technically "in range" at most US labs - and it will leave you exhausted, shedding hair, and unable to tolerate cardio. The reference...
ReadBuild your plan
Take the assessment and we’ll route you into labs, a foundational stack, coaching, or provider review based on what you answer.
